In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: Effects of interleukin (IL)-12 and anti-IL-10

Journal of Infectious Diseases

Volumn 173, Issue 5, 1996, Pages 1085-1091

  Landay, Alan L ^b   Clerici, Mario ^b   Hashcmi, Farah ^b   Kessler, Harold ^b   Berzofsky, Jay A ^b   Shearer, Gene M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; PHYTOHEMAGGLUTININ;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0029899102     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.5.1085     Document Type: Article

References (29)

1. Couillin I, Culmann-Penciolelli B, Gomard E, et al. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immuno-genie region of the human immunodeficiency virus I NEF protein. J Exp Med 1994;180:1129-34.
2. Shearer GM, Salahuddin SZ, Markham PD, et al. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. J Clin Invest 1985;75:1699-704.
3. Gordin FM, Hartigan PM, Klimas NG, et al. Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. J Infect Dis 1994;169:893-7.
4. Clerici M, Stocks NI, Zajec RA, et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J Clin Invest 1989;84:1892-9.
5. Roos MTL, Miedema F, Koot M, et al. T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J Infect Dis 1995;171:531-6.
6. Clerici M, Wynn TA, Berzofsky JA, et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994;93:768-75.
7. + T cell activation. Clin Immunol Immunopathol 1993;67:185-91.
8. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci AS. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome: evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985;313:79-84.
9. + T cell counts. J Infect Dis 1991;164:631-7.
10. + T helper cell depletion occurs. J Clin Invest 1988;82:1908-16.
11. + T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis 1995;172:79-87.
12. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-81.
13. Clerici M, Hakim FT, Venzon DJ, et al. Changes in interleukin-2 and interleukin-4 in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993;91:759-65.
14. Hu R, Oyaizu N, Kalyanaraman VS, et al. HIV-1 gp160 as a modifier of Th1 and Th2 cytokine response: gp160 suppresses interferon-y and interleukin-2 production concomitantly with enhanced interleukin-4 production in vitro. Clin Immunol Immunopathol 1994;73:245-51.
15. Chehimi J, Starr SE, Frank I, et al. Impaired IL-12 production in human immunodeficiency virus-infected patients. J Exp Med 1994;179:1361-6.
16. Kovacs JA, Baseler M, Dwear RJ, et al. Increases in CD4 T lymphocytes with intermitent courses of interleukin-2 in patients with human immunodeficiency virus infection. New Engl J Med 1995;322:567-75.
17. Clerici M, Lucey DR, Berzofsky JA, et al. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993;262:1721-4.
18. Clerici M, Sarin A, Coffman RL, et al. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc NatI Acad Sci USA 1994;91:11811-5.
19. Balter M. Cytokines move from the margins into the spotlight. Science 1995;268:205-6.
20. Chan SH, Perussia B, Gupta JW, et al. Induction of interferon-γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991;173:869-79.
21. D'Andrea A, Amezaga MA, Valiante NM, et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-8.
22. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444-51.
23. + lymphocyte subsets in infants using three-color flow cytometry. Clin Immunol Immunopathol 1994;71:8-13.
24. Clerici M, Stocks NI, Zajac RA, et al. IL-2 production permits detection of antigenic peptide recognition by T helper lymphocytes from asymptomatic, HIV seropositive individuals. Nature 1989;339:383-5.
25. Clerici M, Sison AV, Berzofsky JA, et al. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 1993;7:1427-33.
26. + T cell activation. Clin Immunol Immunopathol 1993;67:185-91.
27. Meyaard L, Otto SA, Jonker RR, et al. Programmed death of T cells in HIV-I infection. Science 1992;257:217-9.
28. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992;175:331-40.
29. Clerici M, Landay AL, Kessler H, et al. Reconstitution of long-term T helper cell function following zidovudine therapy in HIV-infected patients. J Infect Dis 1992;166:723-30.